AAAAAA
Results:
1-12
|
Results: 12
Authors:
Sahlberg-Blom, E
Ternestedt, BM
Johansson, JE
Citation: E. Sahlberg-blom et al., Is good 'quality of life' possible at the end of life? An explorative study of the experiences of a group of cancer patients in two different care cultures, J CLIN NURS, 10(4), 2001, pp. 550-561
Authors:
Johansson, JE
Brune, M
Ekman, T
Citation: Je. Johansson et al., The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning, BONE MAR TR, 28(8), 2001, pp. 737-742
Authors:
Johansson, JE
Ekman, T
Citation: Je. Johansson et T. Ekman, Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings, (vol 19, pg 921, 1997), BONE MAR TR, 27(4), 2001, pp. 462-462
Authors:
Johansson, JE
Soussi, B
Bagge, U
Ekman, T
Citation: Je. Johansson et al., Disturbance of purine nucleotide metabolism - A possible early key event in development of intestinal damage induced by chemotherapy, DIG DIS SCI, 46(2), 2001, pp. 257-261
Authors:
Johansson, JE
Wersall, P
Brandberg, Y
Andersson, SO
Nordstrom, L
Citation: Je. Johansson et al., Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer - A randomized study, SC J UROL N, 35(4), 2001, pp. 288-294
Authors:
Sahlberg-Blom, E
Ternestedt, BM
Johansson, JE
Citation: E. Sahlberg-blom et al., Patient participation in decision making at the end of life as seen by a close relative, NURS ETHICS, 7(4), 2000, pp. 296-313
Authors:
Helgesen, F
Andersson, SO
Gustafsson, O
Varenhorst, E
Goben, B
Carnock, S
Sehlstedt, L
Carlsson, P
Holmberg, L
Johansson, JE
Citation: F. Helgesen et al., Follow-up of prostate cancer patients by on-demand contacts with a specialist nurse - A randomized study, SC J UROL N, 34(1), 2000, pp. 55-61
Authors:
Sahlberg-Blom, E
Ternestedt, BM
Johansson, JE
Citation: E. Sahlberg-blom et al., "Am I going to die now?" - Prognostication of survival time by members of the care team, OMEGA-J D, 42(3), 2000, pp. 219-235
Authors:
Wadelius, M
Andersson, SO
Johansson, JE
Wadelius, C
Rane, A
Citation: M. Wadelius et al., Prostate cancer associated with CYP17 genotype, PHARMACOGEN, 9(5), 1999, pp. 635-639
Authors:
Wadelius, M
Autrup, JL
Stubbins, MJ
Andersson, SO
Johansson, JE
Wadelius, C
Wolf, CR
Autrup, H
Rane, A
Citation: M. Wadelius et al., Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer, PHARMACOGEN, 9(3), 1999, pp. 333-340
Authors:
Johansson, JE
Ekman, T
Citation: Je. Johansson et T. Ekman, Gut mucosa barrier preservation by orally administered IgA-IgG to patientsundergoing bone marrow transplantation: a randomised pilot study, BONE MAR TR, 24(1), 1999, pp. 35-39
Authors:
Sandblom, G
Mattsson, E
Nilsson, J
Damber, JE
Johansson, JE
Lundgren, R
Varenhorst, E
Citation: G. Sandblom et al., Prostate cancer registration in four Swedish regions 1996 - Differences inincidence, age structure and management, SC J UROL N, 33(5), 1999, pp. 306-311
Risultati:
1-12
|